首页 > 最新文献

Case Reports in Ophthalmology最新文献

英文 中文
Usefulness of Color Laser Scanning Ophthalmoscopy and Optical Coherence Tomography Angiography in the Diagnosis of Acute Zonal Occult Outer Retinopathy Complex: A Report of Two Cases. 彩色激光扫描眼底镜与光学相干断层血管造影诊断急性带状隐匿性外视网膜病变复合物2例报告。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-28 eCollection Date: 2025-01-01 DOI: 10.1159/000547672
Hiroki Kawano, Mitsuyoshi Kubota, Toshifumi Yamashita, Keita Yamakiri, Taiji Sakamoto, Hiroto Terasaki, Akinori Uemura

Introduction: The term "acute zonal occult outer retinopathy (AZOOR) complex" encompasses a group of conditions associated with photoreceptor damage, and most patients with AZOOR complex experience irreversible visual-field defects and retinal pigment epithelium atrophy with no effective treatment. Herein, we report two cases of AZOOR complex in which multimodal imaging, including color scanning laser ophthalmoscopy (SLO) and en face optical coherence tomography (OCT) angiography (OCTA), facilitated diagnosis and monitoring.

Case presentation: Case 1 involved a 23-year-old woman who presented with visual-field disturbances in the left eye. The OCT B-scan revealed ellipsoid zone (EZ) irregularities, and color SLO and en face OCTA of the EZ slab showed corresponding hyporeflective areas in the green channel and hypointense regions, respectively. Case 2 involved a 38-year-old woman with decreased visual acuity in the left eye. Imaging findings were similar to those in case 1, and color SLO and en face OCTA revealed abnormalities corresponding to the EZ disruption. In both cases, follow-up imaging revealed improvement in EZ integrity and corresponding changes in color SLO and OCTA findings.

Conclusion: Multimodal imaging using color SLO and en face OCTA provide valuable information regarding the extent and progression of photoreceptor damage in AZOOR complex, which supplement the conventional OCT B-scan findings. These modalities may enhance the diagnostic accuracy and monitoring of patients with AZOOR complex.

简介:“急性带状隐匿性外视网膜病变(AZOOR)复合体”包括一组与光感受器损伤相关的疾病,大多数AZOOR复合体患者经历不可逆的视野缺损和视网膜色素上皮萎缩,没有有效的治疗。在此,我们报告了两例AZOOR复合体,其中多模态成像,包括彩色扫描激光眼科检查(SLO)和面光学相干断层扫描(OCT)血管造影(OCTA),有助于诊断和监测。病例介绍:病例1涉及一名23岁的女性,她表现为左眼视野障碍。OCT b扫描显示椭球区(EZ)不规则,EZ板的彩色SLO和正面OCTA分别在绿色通道和低频区显示相应的低反射区。病例2为一名38岁女性,左眼视力下降。成像结果与病例1相似,彩色SLO和正面OCTA显示与EZ破坏相对应的异常。在这两例患者中,随访成像均显示EZ完整性改善,彩色SLO和OCTA检查结果也相应改变。结论:彩色SLO和面OCTA的多模态成像为AZOOR复合体光感受器损伤的程度和进展提供了有价值的信息,补充了传统OCT b扫描的结果。这些模式可以提高AZOOR患者的诊断准确性和监测。
{"title":"Usefulness of Color Laser Scanning Ophthalmoscopy and Optical Coherence Tomography Angiography in the Diagnosis of Acute Zonal Occult Outer Retinopathy Complex: A Report of Two Cases.","authors":"Hiroki Kawano, Mitsuyoshi Kubota, Toshifumi Yamashita, Keita Yamakiri, Taiji Sakamoto, Hiroto Terasaki, Akinori Uemura","doi":"10.1159/000547672","DOIUrl":"10.1159/000547672","url":null,"abstract":"<p><strong>Introduction: </strong>The term \"acute zonal occult outer retinopathy (AZOOR) complex\" encompasses a group of conditions associated with photoreceptor damage, and most patients with AZOOR complex experience irreversible visual-field defects and retinal pigment epithelium atrophy with no effective treatment. Herein, we report two cases of AZOOR complex in which multimodal imaging, including color scanning laser ophthalmoscopy (SLO) and en face optical coherence tomography (OCT) angiography (OCTA), facilitated diagnosis and monitoring.</p><p><strong>Case presentation: </strong>Case 1 involved a 23-year-old woman who presented with visual-field disturbances in the left eye. The OCT B-scan revealed ellipsoid zone (EZ) irregularities, and color SLO and en face OCTA of the EZ slab showed corresponding hyporeflective areas in the green channel and hypointense regions, respectively. Case 2 involved a 38-year-old woman with decreased visual acuity in the left eye. Imaging findings were similar to those in case 1, and color SLO and en face OCTA revealed abnormalities corresponding to the EZ disruption. In both cases, follow-up imaging revealed improvement in EZ integrity and corresponding changes in color SLO and OCTA findings.</p><p><strong>Conclusion: </strong>Multimodal imaging using color SLO and en face OCTA provide valuable information regarding the extent and progression of photoreceptor damage in AZOOR complex, which supplement the conventional OCT B-scan findings. These modalities may enhance the diagnostic accuracy and monitoring of patients with AZOOR complex.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"711-719"},"PeriodicalIF":0.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual Recovery in Leber's Hereditary Optic Neuropathy Plus: A Case Report and Literature Insight. Leber遗传性视神经病变的视力恢复:一个病例报告和文献见解。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-28 eCollection Date: 2025-01-01 DOI: 10.1159/000547946
Radhika Paranjpe, Himani Yadav, Preethi Abraham, Kalibo Jakhalu

Introduction: Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that primarily affects young men, leading to subacute, painless, bilateral loss of central vision. It is caused by point mutations in mitochondrial DNA, especially those involving the MT-ND1, MT-ND4, and MT-ND6 genes, which disrupt complex I function in the mitochondrial respiratory chain.

Case presentation: We describe an 18-year-old male cricket player who presented with a 6-month history of gradually worsening, painless visual loss in both eyes. His best corrected visual acuity was 6/60 in the right eye and 3/60 in the left eye. Color vision was reduced in the left eye but improved when tested with a red filter, raising suspicion of optic nerve pathology. Fundus examination revealed subtle hyperemic optic discs, and visual field testing identified central and paracentral scotomas. MRI of the orbits showed bilateral T2 hyperintensities in the intraorbital portions of the optic nerves. Genetic testing confirmed a homoplasmic MT:14484C>T mutation in the MT-ND6 gene. The patient also reported systemic symptoms including palpitations and excessive sweating. Cardiac evaluation revealed mitral valve prolapse, sinus tachycardia, and elevated blood pressure. These findings led to a diagnosis of Leber's hereditary optic neuropathy plus (LHON plus). He was started on coenzyme Q10 and oral nutritional supplements. Remarkably, over the course of a year, he regained full visual acuity with only residual optic disc pallor.

Conclusion: This case underscores the importance of considering LHON plus in young patients with bilateral optic neuropathy and systemic features, particularly when the MT:14484C>T mutation is present, as early mitochondrial support can lead to favorable outcomes.

Leber's遗传性视神经病变(LHON)是一种主要影响年轻男性的母系遗传性线粒体疾病,可导致亚急性、无痛性、双侧中枢视力丧失。它是由线粒体DNA的点突变引起的,特别是涉及MT-ND1, MT-ND4和MT-ND6基因的突变,这些突变破坏了线粒体呼吸链中的复合物I功能。病例介绍:我们描述了一位18岁的男性板球运动员,他提出了6个月的历史,逐渐恶化,双眼无痛性视力丧失。他的最佳矫正视力为右眼6/60,左眼3/60。左眼的色觉下降,但在使用红色滤光片进行测试时有所改善,这引起了人们对视神经病变的怀疑。眼底检查显示轻微的视盘充血,视野检查发现中央和中央旁暗点。眼眶MRI显示双侧视神经眶内部分T2高信号。基因检测证实MT- nd6基因同源MT:14484C>T突变。患者还报告了包括心悸和出汗过多在内的全身症状。心脏检查显示二尖瓣脱垂、窦性心动过速和血压升高。这些结果导致诊断为Leber遗传性视神经病变(LHON +)。他开始服用辅酶Q10和口服营养补充剂。值得注意的是,在一年的时间里,他恢复了完全的视力,只剩下视盘苍白。结论:该病例强调了在患有双侧视神经病变和全身性特征的年轻患者中考虑LHON +的重要性,特别是当存在MT:14484C>T突变时,因为早期线粒体支持可导致良好的结果。
{"title":"Visual Recovery in Leber's Hereditary Optic Neuropathy Plus: A Case Report and Literature Insight.","authors":"Radhika Paranjpe, Himani Yadav, Preethi Abraham, Kalibo Jakhalu","doi":"10.1159/000547946","DOIUrl":"10.1159/000547946","url":null,"abstract":"<p><strong>Introduction: </strong>Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that primarily affects young men, leading to subacute, painless, bilateral loss of central vision. It is caused by point mutations in mitochondrial DNA, especially those involving the <i>MT-ND1</i>, <i>MT-ND4</i>, and <i>MT-ND6</i> genes, which disrupt complex I function in the mitochondrial respiratory chain.</p><p><strong>Case presentation: </strong>We describe an 18-year-old male cricket player who presented with a 6-month history of gradually worsening, painless visual loss in both eyes. His best corrected visual acuity was 6/60 in the right eye and 3/60 in the left eye. Color vision was reduced in the left eye but improved when tested with a red filter, raising suspicion of optic nerve pathology. Fundus examination revealed subtle hyperemic optic discs, and visual field testing identified central and paracentral scotomas. MRI of the orbits showed bilateral T2 hyperintensities in the intraorbital portions of the optic nerves. Genetic testing confirmed a homoplasmic MT:14484C>T mutation in the <i>MT-ND6</i> gene. The patient also reported systemic symptoms including palpitations and excessive sweating. Cardiac evaluation revealed mitral valve prolapse, sinus tachycardia, and elevated blood pressure. These findings led to a diagnosis of Leber's hereditary optic neuropathy plus (LHON plus). He was started on coenzyme Q10 and oral nutritional supplements. Remarkably, over the course of a year, he regained full visual acuity with only residual optic disc pallor.</p><p><strong>Conclusion: </strong>This case underscores the importance of considering LHON plus in young patients with bilateral optic neuropathy and systemic features, particularly when the MT:14484C>T mutation is present, as early mitochondrial support can lead to favorable outcomes.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"686-692"},"PeriodicalIF":0.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eight-And-A-Half Syndrome Treated with Stem Cell Therapy: Are We There Yet? A Case Report. 干细胞治疗8.5综合征:我们成功了吗?一个病例报告。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-27 eCollection Date: 2025-01-01 DOI: 10.1159/000548081
Salmarezka Dewiputri, Annisa C Permadi, Ajeng S Kirana, Mohamad Sidik, Yetty Ramli

Introduction: Eight-and-a-half syndrome is a rare neuro-ophthalmologic condition that is often caused by stroke and requires comprehensive ophthalmologic and neurologic management. Stem cell therapy has emerged as a novel and promising candidate approach for the treatment of stroke. This case highlights the potential of stem cell therapy in treating eight-and-a-half syndrome associated with ischemic stroke.

Case presentation: This report presents a 65-year-old male who has experienced double vision for 1 month before admission. Physical examination revealed slight esotropia, horizontal gaze palsy to the right side, incomplete adduction of the right eye, gaze-evoked nystagmus to the left side, and right-sided facial and limb weakness due to ischemic strokes. Visual field impairment was right inferior homonymous quadrantanopia. Based on these findings, the patient was diagnosed with one-and-a-half syndrome and facial nerve weakness, together forming the classic presentation of eight-and-a-half syndrome. He had two cerebrovascular events, only a week apart, and a background history of subsequent atrial fibrillation. MRI revealed left temporoparietal and pontine infarcts. Despite thrombolysis and thrombectomy, the symptoms persisted. He later received intravenous and intrathecal stem cell therapy, showing significant improvement in gaze palsy, visual field, and motor function within a month.

Conclusion: Stem cell therapy might be advantageous for patients with eight-and-a-half syndrome due to ischemic stroke in the subacute and chronic phases.

简介:八半综合征是一种罕见的神经眼科疾病,通常由中风引起,需要综合的眼科和神经学治疗。干细胞疗法已成为一种新颖而有前途的治疗中风的候选方法。这个病例强调了干细胞治疗缺血性中风相关的8.5综合征的潜力。病例介绍:本报告报告一位65岁男性,入院前1个月出现重视。体格检查显示轻度内斜视,右侧水平凝视性麻痹,右眼内收不全,左侧凝视性眼球震颤,缺血性脑卒中所致右侧面部及肢体无力。视野受损为右下同形象限视。基于这些发现,患者被诊断为一半综合征和面神经无力,共同形成了八半综合征的经典表现。他有两次脑血管事件,仅相隔一周,并有后续心房颤动的背景病史。MRI显示左侧颞顶和脑桥梗死。尽管溶栓和取栓,症状仍然存在。随后接受静脉注射和鞘内干细胞治疗,一个月内凝视性麻痹、视野和运动功能明显改善。结论:干细胞治疗对缺血性脑卒中亚急性期和慢性期8 -半综合征患者有较好的疗效。
{"title":"Eight-And-A-Half Syndrome Treated with Stem Cell Therapy: Are We There Yet? A Case Report.","authors":"Salmarezka Dewiputri, Annisa C Permadi, Ajeng S Kirana, Mohamad Sidik, Yetty Ramli","doi":"10.1159/000548081","DOIUrl":"10.1159/000548081","url":null,"abstract":"<p><strong>Introduction: </strong>Eight-and-a-half syndrome is a rare neuro-ophthalmologic condition that is often caused by stroke and requires comprehensive ophthalmologic and neurologic management. Stem cell therapy has emerged as a novel and promising candidate approach for the treatment of stroke. This case highlights the potential of stem cell therapy in treating eight-and-a-half syndrome associated with ischemic stroke.</p><p><strong>Case presentation: </strong>This report presents a 65-year-old male who has experienced double vision for 1 month before admission. Physical examination revealed slight esotropia, horizontal gaze palsy to the right side, incomplete adduction of the right eye, gaze-evoked nystagmus to the left side, and right-sided facial and limb weakness due to ischemic strokes. Visual field impairment was right inferior homonymous quadrantanopia. Based on these findings, the patient was diagnosed with one-and-a-half syndrome and facial nerve weakness, together forming the classic presentation of eight-and-a-half syndrome. He had two cerebrovascular events, only a week apart, and a background history of subsequent atrial fibrillation. MRI revealed left temporoparietal and pontine infarcts. Despite thrombolysis and thrombectomy, the symptoms persisted. He later received intravenous and intrathecal stem cell therapy, showing significant improvement in gaze palsy, visual field, and motor function within a month.</p><p><strong>Conclusion: </strong>Stem cell therapy might be advantageous for patients with eight-and-a-half syndrome due to ischemic stroke in the subacute and chronic phases.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"703-710"},"PeriodicalIF":0.6,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral Peri-Orbital Oedema and Mechanical Ptosis: An Unusual Case Presentation of Rosacea. 单侧眶周水肿及机械性上睑下垂:一例罕见的酒渣鼻。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-26 eCollection Date: 2025-01-01 DOI: 10.1159/000548178
Sze Wai Rosa Li, Noah Clancy, Laszlo Intzedy, Natalie Stone, Ebube Obi

Introduction: Rosacea is an inflammatory skin condition that can present with varied ophthalmic manifestations. It is often overlooked by clinicians especially when unilateral in presentation leading to diagnostic delay and a resultant psychosocial impact. We aimed to present a unique case of ocular rosacea, highlighting the difficulty in therapeutic challenges and diagnoses in such rare cases.

Case presentation: A 64-year-old Caucasian man presented with a 9-month history of persistent painless swelling of the right upper eyelid and secondary ptosis. His ophthalmic examination, serology, and MRI were otherwise normal besides mild meibomian gland dysfunction. Punch biopsy results were inconsistent and initially led to a misdiagnosis of benign squamous papillomata and, later, a differential diagnosis of dermatomyositis. He was trialled on appropriate management for these conditions without any benefit. Repeat histopathology was suggestive of rosacea, and given the persistence of symptoms despite multiple treatments, he was successfully managed with a right upper lid debulking biopsy transcutaneous blepharoplasty. Histopathological analysis of the debulking biopsy confirmed the diagnosis of rosacea, with additional features indicative of lymphoedema. Upon follow-up, there was resolution of lid swelling.

Conclusion: Due to the non-specific nature of isolated ocular rosacea presentations, it can be easily misdiagnosed and, therefore, should always be considered as a differential diagnosis in persistent peri-orbital oedema. It can additionally pose significant therapeutic challenges for ophthalmologists, underscoring the importance of improving our understanding of ocular rosacea. Further, we have shown the effectiveness of surgical debulking in its management.

酒渣鼻是一种炎症性皮肤病,可表现为多种眼部表现。它经常被临床医生忽视,特别是当单侧表现导致诊断延迟和由此产生的社会心理影响时。我们的目的是提出一个独特的情况下,眼酒渣鼻,突出困难的治疗挑战和诊断在这种罕见的情况下。病例介绍:64岁白人男性,右上眼睑持续无痛性肿胀及继发性上睑下垂9个月。除轻度睑板腺功能障碍外,眼科检查、血清学检查及MRI检查均正常。穿刺活检结果不一致,最初导致误诊为良性鳞状乳头状瘤,后来误诊为皮肌炎。他接受了对这些情况进行适当管理的试验,但没有任何效果。重复组织病理学提示酒渣鼻,尽管多次治疗,但症状持续存在,我们成功地对他进行了右上眼睑减容活检。组织病理学分析证实了酒渣鼻的诊断,并伴有淋巴水肿的附加特征。经随访,眼睑肿胀消退。结论:由于孤立性眼红斑痤疮表现的非特异性,它很容易被误诊,因此,在持续性眼眶周围水肿时应始终作为鉴别诊断。它还会对眼科医生提出重大的治疗挑战,强调提高我们对眼酒渣鼻的理解的重要性。此外,我们已经证明了手术切除在其治疗中的有效性。
{"title":"Unilateral Peri-Orbital Oedema and Mechanical Ptosis: An Unusual Case Presentation of Rosacea.","authors":"Sze Wai Rosa Li, Noah Clancy, Laszlo Intzedy, Natalie Stone, Ebube Obi","doi":"10.1159/000548178","DOIUrl":"10.1159/000548178","url":null,"abstract":"<p><strong>Introduction: </strong>Rosacea is an inflammatory skin condition that can present with varied ophthalmic manifestations. It is often overlooked by clinicians especially when unilateral in presentation leading to diagnostic delay and a resultant psychosocial impact. We aimed to present a unique case of ocular rosacea, highlighting the difficulty in therapeutic challenges and diagnoses in such rare cases.</p><p><strong>Case presentation: </strong>A 64-year-old Caucasian man presented with a 9-month history of persistent painless swelling of the right upper eyelid and secondary ptosis. His ophthalmic examination, serology, and MRI were otherwise normal besides mild meibomian gland dysfunction. Punch biopsy results were inconsistent and initially led to a misdiagnosis of benign squamous papillomata and, later, a differential diagnosis of dermatomyositis. He was trialled on appropriate management for these conditions without any benefit. Repeat histopathology was suggestive of rosacea, and given the persistence of symptoms despite multiple treatments, he was successfully managed with a right upper lid debulking biopsy transcutaneous blepharoplasty. Histopathological analysis of the debulking biopsy confirmed the diagnosis of rosacea, with additional features indicative of lymphoedema. Upon follow-up, there was resolution of lid swelling.</p><p><strong>Conclusion: </strong>Due to the non-specific nature of isolated ocular rosacea presentations, it can be easily misdiagnosed and, therefore, should always be considered as a differential diagnosis in persistent peri-orbital oedema. It can additionally pose significant therapeutic challenges for ophthalmologists, underscoring the importance of improving our understanding of ocular rosacea. Further, we have shown the effectiveness of surgical debulking in its management.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"677-685"},"PeriodicalIF":0.6,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145243906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catastrophic Sequelae of Corneal Melt from Severe Active Thyroid Eye Disease in a Patient with Substance Use Disorder: A Case Report. 严重活动性甲状腺眼病伴物质使用障碍患者角膜融化的灾难性后遗症:一例报告。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-23 eCollection Date: 2025-01-01 DOI: 10.1159/000548177
Bahram Eshraghi, Sara KamaliZonouzi, Mohsen Pourazizi, Sarah Ghorbani

Introduction: Thyroid eye disease (TED) is a known complication of Graves' disease, but severe presentations with bilateral corneal melting ulcers are rare. Simultaneous substance use disorder might make the disease management more challenging.

Case presentation: Herein, we present a 29-year-old man with a history of Graves' disease who, despite prior hospitalization for milder symptoms, experienced a deterioration of his condition, leading to bilateral corneal melting ulcers. He was treated with fortified ophthalmic antibiotic drops, and methimazole dosage was increased. Intravenous methylprednisolone and mycophenolate mofetil were also started. Urgent orbital decompression on medial and inferior walls, canthotomy/cantholysis, and medial and lateral tarsorrhaphy were performed, followed by conjunctival flap placement and bilateral total blepharorrhaphy. Despite comprehensive treatment, the patient exhibited a poor therapeutic response and ultimately retained only light perception in both eyes.

Conclusion: The patient's complex medical history including homelessness and substance abuse complicated both diagnosis and management. This case highlights the challenges in treating severe TED and underscores the importance of timely intervention and patient compliance.

简介:甲状腺眼病(TED)是格雷夫斯病的一种已知并发症,但严重表现为双侧角膜融化性溃疡是罕见的。同时发生的物质使用障碍可能使疾病管理更具挑战性。病例介绍:在此,我们报告了一名29岁的男性,他有格雷夫斯病的病史,尽管之前住院治疗的症状较轻,但病情恶化,导致双侧角膜融化溃疡。给予强化眼用抗生素滴剂治疗,并增加甲巯咪唑剂量。同时开始静脉注射甲基强的松龙和霉酚酸酯。进行眶内、下壁紧急减压、眦切开术/眦松解术、内外侧睑板修补术,随后进行结膜瓣置入术和双侧全睑吻合术。尽管进行了综合治疗,但患者表现出较差的治疗反应,最终只保留了双眼的光感。结论:患者的复杂病史,包括无家可归和药物滥用,使诊断和处理复杂化。该病例突出了治疗严重TED的挑战,并强调了及时干预和患者依从性的重要性。
{"title":"Catastrophic Sequelae of Corneal Melt from Severe Active Thyroid Eye Disease in a Patient with Substance Use Disorder: A Case Report.","authors":"Bahram Eshraghi, Sara KamaliZonouzi, Mohsen Pourazizi, Sarah Ghorbani","doi":"10.1159/000548177","DOIUrl":"10.1159/000548177","url":null,"abstract":"<p><strong>Introduction: </strong>Thyroid eye disease (TED) is a known complication of Graves' disease, but severe presentations with bilateral corneal melting ulcers are rare. Simultaneous substance use disorder might make the disease management more challenging.</p><p><strong>Case presentation: </strong>Herein, we present a 29-year-old man with a history of Graves' disease who, despite prior hospitalization for milder symptoms, experienced a deterioration of his condition, leading to bilateral corneal melting ulcers. He was treated with fortified ophthalmic antibiotic drops, and methimazole dosage was increased. Intravenous methylprednisolone and mycophenolate mofetil were also started. Urgent orbital decompression on medial and inferior walls, canthotomy/cantholysis, and medial and lateral tarsorrhaphy were performed, followed by conjunctival flap placement and bilateral total blepharorrhaphy. Despite comprehensive treatment, the patient exhibited a poor therapeutic response and ultimately retained only light perception in both eyes.</p><p><strong>Conclusion: </strong>The patient's complex medical history including homelessness and substance abuse complicated both diagnosis and management. This case highlights the challenges in treating severe TED and underscores the importance of timely intervention and patient compliance.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"671-676"},"PeriodicalIF":0.6,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal Neovascularization following Intra-Arterial Melphalan Chemotherapy for Retinoblastoma. 视网膜母细胞瘤动脉内美法兰化疗后脉络膜新生血管的形成。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI: 10.1159/000547747
Noorhan Amani, Kelvin Du, Michael Goldbaum, Nathan L Scott

Introduction: We present the unique case of a pediatric patient who underwent intra-arterial melphalan chemotherapy and subsequently developed choroidal neovascularization.

Case presentation: A 6-year-old male with a history of nonhereditary unilateral group D retinoblastoma treated with intra-arterial melphalan, cryotherapy, and diode laser consolidative therapy presented to establish care. Initial evaluation revealed a regressed retinoblastoma lesion with chorioretinal scars and calcification scattered in the midperiphery. Notably, the macula was largely within normal limits without evidence of prior malignancy or scarring. However, 7 months after establishing care, imaging was significant for intraretinal fluid, subretinal fluid, and subfoveal fibrosis of the treated eye, suggestive of choroidal neovascularization. The patient was managed with anti-VEGF therapy with resolution of subretinal fluid and improved visual acuity.

Conclusion: This case represents the first description and management of a patient developing choroidal neovascularization after receiving intra-arterial melphalan treatment for retinoblastoma. Careful monitoring of patients following intra-arterial melphalan chemotherapy treatment is critical due to the potential for vision loss, including choroidal neovascularization, which may be an under-reported complication.

简介:我们提出了一个独特的病例,儿童患者接受动脉内美法兰化疗,随后发展脉络膜新生血管。病例介绍:一名6岁男性,有非遗传性单侧D组视网膜母细胞瘤病史,接受动脉内美法兰、冷冻治疗和二极管激光巩固治疗,以建立护理。初步评估显示视网膜母细胞瘤病变消退,并伴有脉络膜瘢痕和散在中周的钙化。值得注意的是,黄斑大部分在正常范围内,没有既往恶性肿瘤或疤痕的证据。然而,在开始治疗7个月后,影像学显示视网膜内液、视网膜下液和治疗眼的中央凹下纤维化,提示脉络膜新生血管形成。患者接受抗vegf治疗,视网膜下液溶解,视力改善。结论:本病例是首例视网膜母细胞瘤患者接受动脉内美法兰治疗后脉络膜新生血管形成的病例。由于潜在的视力丧失,包括脉络膜新生血管形成,这可能是一个未被报道的并发症,因此对动脉内美伐兰化疗后患者的仔细监测是至关重要的。
{"title":"Choroidal Neovascularization following Intra-Arterial Melphalan Chemotherapy for Retinoblastoma.","authors":"Noorhan Amani, Kelvin Du, Michael Goldbaum, Nathan L Scott","doi":"10.1159/000547747","DOIUrl":"10.1159/000547747","url":null,"abstract":"<p><strong>Introduction: </strong>We present the unique case of a pediatric patient who underwent intra-arterial melphalan chemotherapy and subsequently developed choroidal neovascularization.</p><p><strong>Case presentation: </strong>A 6-year-old male with a history of nonhereditary unilateral group D retinoblastoma treated with intra-arterial melphalan, cryotherapy, and diode laser consolidative therapy presented to establish care. Initial evaluation revealed a regressed retinoblastoma lesion with chorioretinal scars and calcification scattered in the midperiphery. Notably, the macula was largely within normal limits without evidence of prior malignancy or scarring. However, 7 months after establishing care, imaging was significant for intraretinal fluid, subretinal fluid, and subfoveal fibrosis of the treated eye, suggestive of choroidal neovascularization. The patient was managed with anti-VEGF therapy with resolution of subretinal fluid and improved visual acuity.</p><p><strong>Conclusion: </strong>This case represents the first description and management of a patient developing choroidal neovascularization after receiving intra-arterial melphalan treatment for retinoblastoma. Careful monitoring of patients following intra-arterial melphalan chemotherapy treatment is critical due to the potential for vision loss, including choroidal neovascularization, which may be an under-reported complication.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"649-654"},"PeriodicalIF":0.6,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Streptococcus dysgalactiae Panophthalmitis and Concurrent Septic Arthritis from Hematogenous Spread: A Case Report. 罕见的半乳糖不全链球菌性眼炎并发脓毒性关节炎血行传播1例。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI: 10.1159/000547764
Lucas Goetz, Michael Eide

Introduction: Panophthalmitis is a severe ocular infection with significant morbidity, most commonly caused by Staphylococcus aureus or Streptococcus pneumoniae. Streptococcus dysgalactiae is a rare cause of panophthalmitis, and its involvement in concurrent systemic infections is exceedingly uncommon.

Case presentation: We report a case of S. dysgalactiae panophthalmitis in an elderly male patient, associated with bacteremia and septic arthritis. Despite early antimicrobial therapy, the infection progressed rapidly, ultimately requiring evisceration of the affected eye.

Conclusion: This case underscores the importance of early recognition, aggressive treatment, and systemic evaluation in patients with rapidly progressive ocular infections caused by atypical organisms.

简介:全眼炎是一种严重的眼部感染,发病率很高,最常由金黄色葡萄球菌或肺炎链球菌引起。半乳糖不良链球菌是一种罕见的全眼炎的原因,它的参与并发全身性感染是非常罕见的。病例介绍:我们报告了一个老年男性患者的S. dysgalactiae全眼炎,伴有菌血症和脓毒性关节炎。尽管早期进行了抗微生物治疗,但感染进展迅速,最终需要切除受感染的眼睛。结论:该病例强调了早期识别、积极治疗和系统评估非典型生物体引起的快速进展性眼部感染的重要性。
{"title":"A Rare Case of <i>Streptococcus dysgalactiae</i> Panophthalmitis and Concurrent Septic Arthritis from Hematogenous Spread: A Case Report.","authors":"Lucas Goetz, Michael Eide","doi":"10.1159/000547764","DOIUrl":"10.1159/000547764","url":null,"abstract":"<p><strong>Introduction: </strong>Panophthalmitis is a severe ocular infection with significant morbidity, most commonly caused by <i>Staphylococcus aureus</i> or <i>Streptococcus pneumoniae</i>. <i>Streptococcus dysgalactiae</i> is a rare cause of panophthalmitis, and its involvement in concurrent systemic infections is exceedingly uncommon.</p><p><strong>Case presentation: </strong>We report a case of <i>S. dysgalactiae</i> panophthalmitis in an elderly male patient, associated with bacteremia and septic arthritis. Despite early antimicrobial therapy, the infection progressed rapidly, ultimately requiring evisceration of the affected eye.</p><p><strong>Conclusion: </strong>This case underscores the importance of early recognition, aggressive treatment, and systemic evaluation in patients with rapidly progressive ocular infections caused by atypical organisms.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"655-660"},"PeriodicalIF":0.6,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Young-Onset Central Retinal Vein Occlusion with Antiphospholipid Syndrome and Hypophysitis. 年轻发病视网膜中央静脉阻塞伴抗磷脂综合征和垂体炎。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI: 10.1159/000548080
Mariko Kawata, Hiromasa Sawamura, Shuichiro Aoki, Kohdai Kitamoto, Yurika Aoyama, Ryo Terao, Tatsuya Inoue, Ryo Obata, Keiko Azuma

Introduction: The aim of the study was to describe a rare case of central retinal vein occlusion (CRVO) in an adolescent with primary antiphospholipid syndrome (APS) and coexisting lymphocytic hypophysitis (LH).

Case presentation: A 17-year-old female presented with acute vision loss in the right eye and was diagnosed with CRVO. She had no cardiovascular risk factors. Fundoscopy revealed optic disc swelling, macular exudates, and venous dilation. Fluorescein angiography demonstrated optic disc leakage without any signs of vasculitis. IgG anticardiolipin antibodies were persistently elevated on two separate occasions, thereby fulfilling the 2023 ACR/EULAR criteria for APS. Magnetic resonance imaging revealed pituitary stalk thickening and asymmetrical intrasellar enhancement, consistent with LH, although visual field loss and optic nerve abnormalities were not detected. A single intravitreal injection of ranibizumab was effective, resulting in complete resolution of serous retinal detachment and improvement in visual acuity. Anticoagulants were also administered. At the 12-month follow-up, no progression of LH was observed.

Conclusion: Coagulation should be thoroughly evaluated in cases of early-onset CRVO without systemic risk factors. This case highlights the importance of considering APS in young patients with CRVO without systemic risk factors. There is a shared immunologic predisposition when coexisting autoimmune disorders such as LH.

简介:本研究的目的是描述一例罕见的视网膜中央静脉阻塞(CRVO)的青少年原发性抗磷脂综合征(APS)和并存的淋巴细胞性垂体炎(LH)。病例介绍:一名17岁女性,右眼急性视力丧失,诊断为CRVO。她没有心血管危险因素。眼底镜检查显示视盘肿胀,黄斑渗出,静脉扩张。荧光素血管造影显示视盘渗漏,无血管炎征象。IgG抗心磷脂抗体在两个不同的情况下持续升高,从而满足2023年ACR/EULAR APS标准。磁共振成像显示垂体柄增厚和鞍内不对称强化,与LH一致,但未发现视野丧失和视神经异常。单次玻璃体内注射雷尼单抗是有效的,导致浆液性视网膜脱离的完全解决和视力的改善。同时给予抗凝剂。在12个月的随访中,未观察到LH进展。结论:对于无系统性危险因素的早发性CRVO患者,应全面评估凝血功能。本病例强调了在没有系统性危险因素的年轻CRVO患者中考虑APS的重要性。当同时存在自身免疫性疾病如黄体生成素时,有共同的免疫易感性。
{"title":"Young-Onset Central Retinal Vein Occlusion with Antiphospholipid Syndrome and Hypophysitis.","authors":"Mariko Kawata, Hiromasa Sawamura, Shuichiro Aoki, Kohdai Kitamoto, Yurika Aoyama, Ryo Terao, Tatsuya Inoue, Ryo Obata, Keiko Azuma","doi":"10.1159/000548080","DOIUrl":"10.1159/000548080","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of the study was to describe a rare case of central retinal vein occlusion (CRVO) in an adolescent with primary antiphospholipid syndrome (APS) and coexisting lymphocytic hypophysitis (LH).</p><p><strong>Case presentation: </strong>A 17-year-old female presented with acute vision loss in the right eye and was diagnosed with CRVO. She had no cardiovascular risk factors. Fundoscopy revealed optic disc swelling, macular exudates, and venous dilation. Fluorescein angiography demonstrated optic disc leakage without any signs of vasculitis. IgG anticardiolipin antibodies were persistently elevated on two separate occasions, thereby fulfilling the 2023 ACR/EULAR criteria for APS. Magnetic resonance imaging revealed pituitary stalk thickening and asymmetrical intrasellar enhancement, consistent with LH, although visual field loss and optic nerve abnormalities were not detected. A single intravitreal injection of ranibizumab was effective, resulting in complete resolution of serous retinal detachment and improvement in visual acuity. Anticoagulants were also administered. At the 12-month follow-up, no progression of LH was observed.</p><p><strong>Conclusion: </strong>Coagulation should be thoroughly evaluated in cases of early-onset CRVO without systemic risk factors. This case highlights the importance of considering APS in young patients with CRVO without systemic risk factors. There is a shared immunologic predisposition when coexisting autoimmune disorders such as LH.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"693-702"},"PeriodicalIF":0.6,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein Analysis of the Surface of Orthokeratology Lenses. 角膜塑形镜表面蛋白分析。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI: 10.1159/000547905
Lars Fjord Garvey, Jennifer Liao, Nikolay Boychev, Marlies Gijs, Ananya Datta, Bent Honoré, Henrik Vorum, Lasse Jørgensen Cehofski, Flemming Møller, Trine Møldrup Jakobsen

Introduction: Overnight orthokeratology (OK) lenses control myopia in children, but the underlying mechanism is unclear. We hypothesized that ocular surface proteins might deposit directly on the surface of OK lenses during wear. This could offer a noninvasive method for investigating the potential molecular mechanisms behind the myopia control effect of OK lenses.

Case presentation: A healthy 30-year-old male without prior contact lens wear history wore bespoke OK lenses overnight. After lens removal, proteomic analysis was performed using nano liquid chromatography tandem mass spectrometry to identify proteins on the surface of the lenses. Proteomic analysis identified 423 proteins on the right OK lens and 303 on the left, with 273 proteins common to both lenses. The proteins originated from various cellular compartments.

Conclusion: Ocular surface proteins can be detected directly from OK lenses, offering a novel approach to studying the molecular mechanisms of myopia control.

夜间角膜塑形镜(OK)可控制儿童近视,但其作用机制尚不清楚。我们假设眼表蛋白可能在佩戴过程中直接沉积在OK晶状体表面。这为研究OK晶状体控制近视作用的潜在分子机制提供了一种无创方法。病例介绍:一位健康的30岁男性,之前没有佩戴隐形眼镜的历史,戴了定制的OK隐形眼镜过夜。去除晶状体后,使用纳米液相色谱串联质谱法进行蛋白质组学分析,以鉴定晶状体表面的蛋白质。蛋白质组学分析发现,右侧OK晶状体有423种蛋白质,左侧OK晶状体有303种蛋白质,其中273种蛋白质是两种晶状体共有的。这些蛋白质来自不同的细胞区室。结论:OK晶状体可直接检测到眼表蛋白,为研究近视控制的分子机制提供了新的途径。
{"title":"Protein Analysis of the Surface of Orthokeratology Lenses.","authors":"Lars Fjord Garvey, Jennifer Liao, Nikolay Boychev, Marlies Gijs, Ananya Datta, Bent Honoré, Henrik Vorum, Lasse Jørgensen Cehofski, Flemming Møller, Trine Møldrup Jakobsen","doi":"10.1159/000547905","DOIUrl":"10.1159/000547905","url":null,"abstract":"<p><strong>Introduction: </strong>Overnight orthokeratology (OK) lenses control myopia in children, but the underlying mechanism is unclear. We hypothesized that ocular surface proteins might deposit directly on the surface of OK lenses during wear. This could offer a noninvasive method for investigating the potential molecular mechanisms behind the myopia control effect of OK lenses.</p><p><strong>Case presentation: </strong>A healthy 30-year-old male without prior contact lens wear history wore bespoke OK lenses overnight. After lens removal, proteomic analysis was performed using nano liquid chromatography tandem mass spectrometry to identify proteins on the surface of the lenses. Proteomic analysis identified 423 proteins on the right OK lens and 303 on the left, with 273 proteins common to both lenses. The proteins originated from various cellular compartments.</p><p><strong>Conclusion: </strong>Ocular surface proteins can be detected directly from OK lenses, offering a novel approach to studying the molecular mechanisms of myopia control.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"644-648"},"PeriodicalIF":0.6,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastasis of Neuroendocrine Carcinoma Masquerading as a Chalazion. 伪装成肿瘤的神经内分泌癌的转移。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2025-08-18 eCollection Date: 2025-01-01 DOI: 10.1159/000547525
Sofía Ramos-Bartolomei, José López-Fontanet, Sofía Muns-Aponte, José Raúl Montes, Miguel Noy

Introduction: Nonhealing or rapidly growing lesions should raise suspicion for malignancy, especially in a patient with a prior history of cancer. The purpose of this case was to highlight the importance of a thorough clinical history. A high index of suspicion and low threshold for biopsy are important, as is a fast diagnosis, as they can make a difference in adequate treatment and prognosis.

Case presentation: We present a case of a 46-year-old female with a history of invasive ductal carcinoma of the breast presenting with a rapidly growing painless right lower eyelid lesion with biopsy remarkable for a high-grade neuroendocrine carcinoma suspected to be a result of metastasis with rare transformation of breast ductal carcinoma.

Conclusion: She had an eyelid lesion recurrence less than 2 months after biopsy and excision, demonstrating the importance of early detection and biopsy with immunohistochemistry to target malignant cells and improve life quality and expectancy.

不愈合或快速生长的病变应引起对恶性肿瘤的怀疑,特别是对有癌症病史的患者。本病例的目的是强调全面的临床病史的重要性。高怀疑指数和低活检阈值很重要,快速诊断也很重要,因为它们可以在适当的治疗和预后方面发挥作用。病例报告:我们报告一位46岁女性,有浸润性乳腺导管癌病史,表现为右下眼睑快速生长的无痛性病变,活检显示为高度神经内分泌癌,怀疑是转移的结果,罕见的乳腺导管癌转化。结论:该患者在活检切除后不到2个月眼睑病变复发,说明早期发现和免疫组化活检对靶向恶性细胞,提高生活质量和预期寿命的重要性。
{"title":"Metastasis of Neuroendocrine Carcinoma Masquerading as a Chalazion.","authors":"Sofía Ramos-Bartolomei, José López-Fontanet, Sofía Muns-Aponte, José Raúl Montes, Miguel Noy","doi":"10.1159/000547525","DOIUrl":"10.1159/000547525","url":null,"abstract":"<p><strong>Introduction: </strong>Nonhealing or rapidly growing lesions should raise suspicion for malignancy, especially in a patient with a prior history of cancer. The purpose of this case was to highlight the importance of a thorough clinical history. A high index of suspicion and low threshold for biopsy are important, as is a fast diagnosis, as they can make a difference in adequate treatment and prognosis.</p><p><strong>Case presentation: </strong>We present a case of a 46-year-old female with a history of invasive ductal carcinoma of the breast presenting with a rapidly growing painless right lower eyelid lesion with biopsy remarkable for a high-grade neuroendocrine carcinoma suspected to be a result of metastasis with rare transformation of breast ductal carcinoma.</p><p><strong>Conclusion: </strong>She had an eyelid lesion recurrence less than 2 months after biopsy and excision, demonstrating the importance of early detection and biopsy with immunohistochemistry to target malignant cells and improve life quality and expectancy.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"628-632"},"PeriodicalIF":0.6,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Case Reports in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1